Retatrutide is the newest and most powerful weight loss helper. While other medicines press one or two buttons in your body, this one presses THREE! It controls hunger, helps your body use sugar better, AND speeds up how fast you burn fat.
Think of it like: Think of your body like a video game where you want to beat the 'extra weight' level. Retatrutide gives you THREE power-ups at once: one to feel less hungry, one to use energy better, and one to burn fat faster. It's like having a triple combo attack!
Triple agonist (GLP-1/GIP/Glucagon) representing the next generation of weight loss peptides. Retatrutide activates three hormone pathways for potentially maximum weight loss efficacy, showing up to 24% body weight reduction in phase 2 trials.
Appetite Regulation
Peptides mimic satiety hormones, reducing hunger signals from the brain.
Quickstart Highlights
- Dosage: 1-12mg
- Frequency: Weekly
- Administration: Subcutaneous injection
- Cycle length: Ongoing (maintenance)
Dosing Plan
| Weeks | Dose | Units |
|---|---|---|
| Weeks 1–4 | 1mg once weekly | 20 units (0.2mL) from 5mg/mL |
| Weeks 5–8 | 2mg once weekly | 40 units (0.4mL) |
| Weeks 9–12 | 4mg once weekly | 80 units (0.8mL) |
| Weeks 13–16 | 8mg once weekly | Use 10mg vial |
| Week 17+ (Maintenance) | 12mg once weekly | Maximum efficacy dose |
How to mix
2ml BAC water per 5-10mg vial
- Draw 2.0mL bacteriostatic water for a 5mg/mL concentration.
- Inject slowly down the vial wall.
- Gently swirl until completely dissolved.
- Label with date and concentration.
- Refrigerate at 2–8°C immediately.
Syringe Math Reference
- 5mg vial with 2mL BAC water = 2.5 mg/mL
- 10mg vial with 2mL BAC water = 5 mg/mL
- 1mg dose from 5mg/mL = 20 units (0.2mL)
- 4mg dose from 5mg/mL = 80 units (0.8mL)
- 8mg dose from 5mg/mL = requires fresh vial or higher concentration
What you'll need
Retatrutide Vials (5mg or 10mg)
- 4 weeks 1 vial
- 8 weeks 2 vials
- 12 weeks 3-4 vials
Insulin Syringes (U-100)
- 4 weeks 4 syringes
- 8 weeks 8 syringes
- 12 weeks 12 syringes
Bacteriostatic Water (10mL)
- 4 weeks 1 bottle
- 8 weeks 1 bottle
- 12 weeks 2 bottles
Alcohol Swabs
- 4 weeks 1 × 100-count box
- 8 weeks 1 × 100-count box
- 12 weeks 1 × 100-count box
How This Works
Retatrutide is a triple hormone receptor agonist that activates GLP-1, GIP, and glucagon receptors simultaneously. While GLP-1 and GIP work to suppress appetite and improve insulin sensitivity, the glucagon component increases energy expenditure and promotes fat oxidation in the liver. This three-pronged approach addresses multiple metabolic pathways, potentially explaining the remarkable weight loss results seen in clinical trials.
Mechanism of Action
How Retatrutide Works in Your Body
Peptide Administered
Enters bloodstream and travels to target receptors
Brain Signaling
Binds to GLP-1 receptors in the hypothalamus
Appetite Reduced
Signals satiety — you feel full sooner
Fat Metabolism
Body shifts to burning stored fat for energy
Benefits & Side Effects
Potential Benefits
- Up to 24% body weight loss in phase 2 trials (highest of any weight loss drug)
- Enhanced metabolic rate through glucagon activation
- Improved insulin sensitivity and glucose control
- Increased fat oxidation and energy expenditure
- Potential liver fat reduction through glucagon pathway
- Comprehensive metabolic health improvement
Potential Side Effects
- Nausea and vomiting (common during titration)
- Diarrhea or constipation
- Decreased appetite (may be significant)
- Potential blood sugar fluctuations from glucagon
- Injection site reactions
- Limited long-term safety data (research compound)
How to store it
- Lyophilized: Store frozen at -20°C for long-term, refrigerated for short-term.
- Reconstituted: Refrigerate at 2–8°C; use within 28 days.
- Protect from light and heat.
- Do not freeze reconstituted solution.
Good to know
- Retatrutide is still in clinical trials and not yet FDA approved.
- The glucagon receptor activation may increase metabolic rate and energy expenditure.
- May cause more pronounced appetite suppression than dual agonists.
- Titration is essential - the glucagon component may cause initial side effects.
- Monitor liver function as glucagon affects hepatic metabolism.
- Research compound - use with appropriate caution and medical supervision.
Community Insights
Summarised from 10 sourcesCommunity discussions suggest Retatrutide is viewed as a "better overall drug" compared to Semaglutide or Tirzepatide, especially for benefits beyond pure appetite suppression. Users report significant weight loss, with some losing 22 lbs in one month and 40 lbs "so far." It seems to be effective when combined with a strict regimen of diet and exercise. There's also discussion around dosage titration, with users starting low and gradually increasing, with some reaching 3mg per week. The community emphasizes individual responses to the peptide and the importance of personal research. While generally positive, some users note that for pure appetite suppression, other peptides might be more effective. The impact on endurance training is also a topic of discussion among athletes. The information shared is based on personal experiences and not medical advice.
Key Benefits
- significant weight loss (22-40 lbs reported)
- considered a "better overall drug" by some users
- effective with diet and exercise regimen
Common Dosages Reported
- starting at 1mg and titrating up to 3mg over 6 weeks
- 1mg administered initially
- low dose regimen every other day (Dr. Bachmeyer guy concept)
Side Effects Mentioned
- mild to no side effects reported by some
- individual variation in side effects is emphasized
- less effective for "pure appetite suppression" compared to sema/tirz
What people are saying
"My experience with Retatrutide" discussion suggests it's a good overall drug
"down 40lbs" and "amazing for weight loss"
"Lost 22lbs in one month on Retatrutide"
"8-week transformation on Retatrutide: 32 lbs"
Reviews & Discussion
Real experiences shared by the community — not medical advice.
Potency and Plateau Breaking
A user reported that Retatrutide is significantly more potent than Tirzepatide, noting it is roughly double the strength. They successfully used it to break through a weight loss plateau that occurred while using Tirzepatide.
Diminishing Effects After Three Months
A user reported that Retatrutide ceased to be effective after three months of consistent use at the same dosage. They sought advice on whether to increase the dose or if they had reached a plateau.
Clinical Overview of Triple Agonist Benefits
A clinical review article highlights Retatrutide as a breakthrough triple agonist targeting GLP-1, GIP, and glucagon receptors. It notes that this mechanism may offer superior weight reduction and metabolic improvement compared to Semaglutide and Tirzepatide by enhancing energy expenditure alongside appetite suppression.
Successful Long-term Use by Spouse
A user mentioned that his wife has been using Retatrutide for several months with very good results. These positive observations influenced his own decision to start the peptide for fat loss.
Rapid Weight Loss with No Side Effects
A user reported losing 8 pounds within the first two weeks of using Retatrutide to target stubborn belly fat. Unlike their previous negative experiences with Semaglutide and Tirzepatide, which caused severe gastrointestinal issues, they experienced zero side effects with this triple-agonist peptide.
Increased Resting Metabolic Rate (RMR) at 6mg
A user utilized 6mg of Retatrutide per week (split into three 2mg doses) during a cutting phase. Post-cycle testing showed their Resting Metabolic Rate (RMR) was approximately 225 calories higher than the expected average for their stats.
Weight Loss with Significant Lethargy and Low Libido
A user successfully lost 18kg using Retatrutide but reported experiencing significant lethargy, lack of motivation, and crushed libido. These effects were attributed to the combined impact of a prolonged calorie deficit and the peptide's pharmacological effects.
High Resting Heart Rate at 3-4mg
A user reported that increasing their Retatrutide dosage to 3-4mg caused an excessively high resting heart rate (RHR). They discontinued use for six weeks to allow their RHR and heart rate variability (HRV) to return to normal levels.
Effective Weight Loss at 3mg Weekly
A user reported success with a slow titration starting at 1mg and reaching 3mg per week over 10 weeks. They experienced effective weight loss with only minor constipation and appreciated that they could still eat comfortably without feeling sick.
Retatrutide and AC-262 Cutting Cycle
A user reported utilizing Retatrutide alongside AC-262 during a cutting phase to successfully manage weight. They noted that the combination allowed them to regain their physical baseline quickly after an illness while maintaining higher energy levels and confidence.
Retatrutide for Lipid Management during SARM Cycle
A user inquired about the efficacy of running Retatrutide alongside ACP-105 specifically to counteract the SARM's negative impact on lipid profiles. They highlighted Retatrutide's potential clinical benefits for cardiovascular health and lipid management as a primary reason for the stack.
Comparison of Retatrutide to new GLP-4 compounds
A user discussed a new drug candidate (NA-931) and compared its efficacy to Retatrutide, noting that Retatrutide is known for significant weight loss effects. The comparison highlighted Retatrutide's potency in the GLP-1/GIP/GCG agonist category.
Positive non-weight loss effects and tobacco cessation
A user reported significant benefits beyond weight loss while using Retatrutide, including successfully quitting smoking and nicotine gum. They also noted that the peptide allowed them to discontinue blood pressure medication and provided an overall improvement in their mental well-being when at a steady state.
No discussion yet — be the first.
No notes yet — be the first.